Terms: = Bone cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
425 results:
1. Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee.
McLornan DP; Czerw T; Damaj G; Ethell M; Gurnari C; Hernández-Boluda JC; Polverelli N; Schwaab J; Sockel K; Raffaella G; Onida F; Sánchez-Ortega I; Battipaglia G; Elena C; Gotlib J; Reiter A; Rossignol J; Ustun C; Valent P; Yakoub-Agha I; Radia DH
Leukemia; 2024 Apr; 38(4):699-711. PubMed ID: 38472477
[TBL] [Abstract] [Full Text] [Related]
2. Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.
Cheevapruk K; Ueno M; Sungwan P; Sittithumcharee G; Kariya R; Sampattavanich S; Okada S
Anticancer Res; 2024 Mar; 44(3):1023-1031. PubMed ID: 38423667
[TBL] [Abstract] [Full Text] [Related]
3. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
[TBL] [Abstract] [Full Text] [Related]
4. Regulation of the P53 tumor suppressor gene and the mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.
Akbari P; Taebpour M; Akhlaghi M; Hasan SH; Shahriyari S; Parsaeian M; Haghirosadat BF; Rahdar A; Pandey S
Med Oncol; 2024 Jan; 41(3):68. PubMed ID: 38289404
[TBL] [Abstract] [Full Text] [Related]
5. Osteosarcoma neutrophil extracellular trap network-associated gene recurrence and metastasis model.
Tang H; Xie J; Du YX; Tan ZJ; Liang ZT
J Cancer Res Clin Oncol; 2024 Jan; 150(2):48. PubMed ID: 38285218
[TBL] [Abstract] [Full Text] [Related]
6. Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
7. Broadening the horizon: potential applications of CAR-T cells beyond current indications.
Karsten H; Matrisch L; Cichutek S; Fiedler W; Alsdorf W; Block A
Front Immunol; 2023; 14():1285406. PubMed ID: 38090582
[TBL] [Abstract] [Full Text] [Related]
8. Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
Bock AM; Gile JJ; Larson MC; Poonsombudlert K; Tawfiq RK; Maliske S; Maurer MJ; Kabat BF; Paludo J; Inwards DJ; Ayyappan S; Link BK; Ansell SM; Habermann TM; Witzig TE; Nowakowski GS; Cerhan JR; Farooq U; Wang Y
Blood Cancer J; 2023 Nov; 13(1):169. PubMed ID: 37957158
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA Expression Profile in bone Marrow and Lymph Nodes in B-Cell Lymphomas.
Veryaskina YA; Titov SE; Kovynev IB; Pospelova TI; Fyodorova SS; Shebunyaeva YY; Sumenkova DV; Zhimulev IF
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894763
[TBL] [Abstract] [Full Text] [Related]
10. Computed Tomography Imaging Patterns of Sinonasal Inverted Papillomas: Comparison of Primary and Recurrent Disease.
Talati V; Holland K; Ansari SM; Filip P; Khalife S; Jhaveri MD; Tajudeen BA; Papagiannopoulos P; Batra PS
Laryngoscope; 2024 Apr; 134(4):1591-1596. PubMed ID: 37767874
[TBL] [Abstract] [Full Text] [Related]
11. Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement.
Ryan CE; Zon RL; Redd R; Fisher DC; Shouval R; Kumar A; Crombie JL; Sadrzadeh H; Kim AI; Nayak L; Chukwueke UN; Jacobson CA; Frigault MJ; Palomba ML; Armand P; Epstein-Peterson Z; Merryman RW
Br J Haematol; 2023 Dec; 203(5):774-780. PubMed ID: 37584155
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical features and prognostic factors of elderly patients with mantle cell lymphoma].
Hao XY; Yang P; Zhang W; Liu H; Sun XH; Xiao XB; Wang JW; Li ZL; Li LH; Wang SY; He J; Li XL; Jing HM
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):495-500. PubMed ID: 37550206
[No Abstract] [Full Text] [Related]
13. Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma.
Hill HA; Jain P; Ok CY; Sasaki K; Chen H; Wang ML; Chen K
Cancer Res Commun; 2023 Aug; 3(8):1435-1446. PubMed ID: 37538987
[TBL] [Abstract] [Full Text] [Related]
14. Henoch-Schonlein Purpura, an Unusual Presentation of Acute Myeloid Leukemia.
Butt MA; Aamer S; Kapetanos A
Anticancer Res; 2023 Aug; 43(8):3579-3582. PubMed ID: 37500160
[TBL] [Abstract] [Full Text] [Related]
15. Is liquid nitrogen recycled bone and vascular fibula combination the biological reconstruction of choice in lower extremity long bone tumor-related defects?
Özger H; Alpan B; Eralp L; Valiyev N; Sungur M; Aycan OE; Salduz A
J Surg Oncol; 2023 Oct; 128(5):902-915. PubMed ID: 37428092
[TBL] [Abstract] [Full Text] [Related]
16. Bilateral Lacrimal Gland Mantle Cell Lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature.
Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N
J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948
[TBL] [Abstract] [Full Text] [Related]
17. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Carter BZ; Mak PY; Muftuoglu M; Tao W; Ke B; Pei J; Bedoy AD; Ostermann LB; Nishida Y; Isgandarova S; Sobieski M; Nguyen N; Powell RT; Martinez-Moczygemba M; Stephan C; Basyal M; Pemmaraju N; Boettcher S; Ebert BL; Shpall EJ; Wallner B; Morgan RA; Karras GI; Moll UM; Andreeff M
Blood; 2023 Sep; 142(12):1056-1070. PubMed ID: 37339579
[TBL] [Abstract] [Full Text] [Related]
18. Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinoma.
Liang J; Sun G; Pan X; Zhang M; Shen P; Zhu S; Zhao J; Zheng L; Zhao J; Chen Y; Yin X; Chen J; Hu X; Zeng Y; Chen J; Wang Y; Liu Z; Yao J; Su M; Huang R; Liao B; Wei Q; Li X; Zhou Q; Liu J; Shen Y; Liu Z; Chen N; Zeng H; Zhang X
Genome Med; 2023 May; 15(1):31. PubMed ID: 37131267
[TBL] [Abstract] [Full Text] [Related]
19. Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.
Phillips TJ; Bond D; Takiar R; Kump K; Kandarpa M; Boonstra P; Mayer TL; Nachar V; Wilcox RA; Carty SA; Karimi YH; Nikolovska-Coleska Z; Kaminski MS; Herrera AF; Maddocks K; Popplewell L; Danilov AV
Blood Adv; 2023 Aug; 7(16):4518-4527. PubMed ID: 37013954
[TBL] [Abstract] [Full Text] [Related]
20. The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes.
Kuszczak B; Wróbel T; Wicherska-Pawłowska K; Rybka J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902139
[TBL] [Abstract] [Full Text] [Related]
[Next]
